AI-powered imaging systems and deep learning software

DUBLIN, June 5, 2026 (Globe Newswire) — Added ‘AI in Cancer Diagnostics Market Report 2026’ ResearchAndMarkets.com Offerings.

The AI in cancer diagnostics market is experiencing remarkable rapid growth and is expected to expand from $790 million in 2025 to $960 million in 2026, registering a CAGR of 20.2%. This upward trend is primarily due to the early and limited adoption of AI in diagnostic procedures, reliance on traditional imaging, and increasing global cancer prevalence. Industry momentum is driven by the expanding network of diagnostic centers and increasing demand for early cancer detection solutions.

Future growth of this market is driven by advances in deep learning, machine learning algorithms, and AI-powered imaging systems. Expected to reach $1.97 billion by 2030 at a CAGR of 19.9%, the period is showing promise due to the increasing integration of predictive analytics in healthcare and significant investment in digital health technologies. Collaboration between AI developers and healthcare institutions is creating innovative AI-based diagnostic tools and tumor identification systems, driving market development.

Cancer incidence is a key driver of this market, with the National Cancer Institute predicting that the number of new cancer cases in the United States will reach 2 million in 2024. The number of new cases worldwide is expected to reach 29.9 million by 2040. The focus is on improving personalized care and efficiency through AI to improve patient outcomes. Significant advances are being made in AI-powered digital pathology solutions, with companies such as Dedalus and Ibex Medical Analytics launching integrated AI-powered systems to improve diagnostic accuracy across Europe.

Market restructuring moves include Lunit’s $193 million acquisition of Volpara, strengthening its presence in the U.S. market. Subject to shareholder and court approval, the partnership will leverage Volpara’s extensive database and facility presence to enhance its AI-powered cancer diagnostic capabilities. Prominent companies shaping this market include Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, etc.

Geographically, North America will lead the AI cancer diagnostics market in 2025 with extensive coverage of various regions including Asia Pacific and Europe. Tariffs affecting imported imaging hardware impacted adoption rates, but also encouraged local manufacturing and regional software innovation, particularly in AI-powered imaging systems and deep learning software.

AI in cancer diagnosis is defined by revenue from early detection, image analysis, predictive analytics, and treatment planning services. This market consists of sales of medical imaging equipment, pathology analysis systems, and patient monitoring gadgets and reflects ex-factory value including all related service offerings.

This press release provides comprehensive insights on the evolving AI in cancer diagnostics space, highlighting market size, regional share, competitive dynamics, and segments driving future opportunities. Key components, including software solutions, are improving the detection accuracy of multiple cancer types and are being utilized in comprehensive diagnostic approaches in hospitals, laboratories, and research institutions. This is an important stepping stone for parties looking to increase their AI presence in the growing cancer diagnostics market.

of AI in Cancer Diagnostics Market Global Report 2026 is an essential resource for strategists and marketers, providing an in-depth look at the rapidly growing market and a comprehensive guide to the trends that will shape its future.

Reason for purchase:

Cover 16 key regions and gain a global perspective.
Assess the impact of macro factors such as geopolitical conflicts, trade policy, inflation, and regulatory changes.
Develop region- and country-specific strategies using localized data and analytics.
Use predictive trends and market drivers to identify growth segments and outperform your competitors.
Understand end-user behavior and benchmark against competitors in terms of innovation and market share.
Assess market potential through comprehensive market analysis and attractiveness scoring.
Support your presentations with high-quality data and analysis, accompanied by Excel datasheets for comprehensive evaluation.

The report considers the following: Key market trends characteristics, growth, segmentation, competitive environment, etc. Track market evolution by region and predict trends influenced by technological disruption and regulatory changes.

Market characteristics: Definitions, key products, brand differentiation, and product development trends.
Supply chain analysis: Overview of value chain, raw materials and competitive positioning.
Trends and strategies: Digital transformation, automation, AI-driven innovation, and sustainability initiatives.
Regulatory and investment status: Regulatory frameworks, investment flows and industry growth incentives.
Market size: Analysis of past growth and future financial forecasts.
Total Addressable Market (TAM) Analysis: Estimating potential growth opportunities.
Market attractiveness score: Quantitative assessment based on growth potential and strategic impact.
Regional and country breakdown: Analysis of geographical market size and growth forecast.
Competitive environment: Overview of market competition, major financial transactions, and key companies.
Company score matrix: Rating companies based on market share, innovation, and brand recognition.

Report scope

By component: Software solutions, hardware and services.
By cancer type: Breast cancer, lung cancer, brain cancer, skin cancer, cervical cancer, prostate cancer, colorectal cancer, and other cancers.
By application: Screening, diagnosis, tumor identification, and monitoring.
By end user: Hospitals, diagnostic centers, medical research institutes.

Main companies: Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, etc.

Geographical scope: It includes countries such as Australia, Brazil, China, France, and Germany, and regions such as Asia Pacific, Western Europe, and North America.

This report is updated semi-annually and is customizable to ensure relevance and accuracy. This includes support from expert consultants and is further enhanced by segmentation and sourcing of data across documents.

Key attributes:

report attributes	detail
Number of pages	250
Forecast period	2026-2030
Estimated market value in 2026 (USD)	$960 million
Projected market value to 2030 (USD)	$1.97 billion
compound annual growth rate	19.9%
Target area	global

Featured companies

The companies profiled in this Cancer Diagnostic AI market report are:

Microsoft Corporation
IBM Co., Ltd.
Verily Life Sciences LLC
Tempus Labs Inc.
Guardant Health Co., Ltd.
Runit Co., Ltd.
Page AI Inc
Bizi Co., Ltd.
Enlitic Co., Ltd.
Ibex Medical Analytics Co., Ltd.
KEIRON MEDICAL TECHNOLOGIES LIMITED.
Cure Metrics Co., Ltd.
CancerIQ Inc.
MultiplAI Health Inc
Free Nome Holdings Co., Ltd.
Skin Vision BV
Okin Co., Ltd.
Imagen Technologies Co., Ltd.
Cyrcadia Health Inc.
Oncora Medical Co., Ltd.
Xyris Co., Ltd.

For more information on this report, please visit https://www.researchandmarkets.com/r/6vg3wv.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.